Letter to the Editor
First report of metronidazole-induced QT interval prolongation

https://doi.org/10.1016/j.ijantimicag.2007.10.006Get rights and content

References (7)

  • S. Viskin et al.

    Long QT syndrome caused by non-cardiac drugs

    Prog Cardiovasc Dis

    (2003)
  • D. Justo et al.

    Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports

    Mycoses

    (2006)
  • C.E. Cooke et al.

    Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?

    Ann Pharmacother

    (1996)
There are more references available in the full text version of this article.

Cited by (10)

  • Metronidazole

    2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  • Antiprotozoal drugs

    2010, Side Effects of Drugs Annual
    Citation Excerpt :

    For sulfonamides and co-trimoxazole (trimethoprim + sulfamethoxazole), seeChapter 26. QT interval prolongation after metronidazole has been described (20A). A 90-year-old woman with Parkinson’s disease and osteoporosis was given intravenous ceftriaxone 1 g/day and metronidazole 500 mg tds for an aspiration pneumonia; her other medications included levodopa and calcium.

  • Perioperative acquired long QT syndrome: a case report

    2010, Revista Espanola de Anestesiologia y Reanimacion
  • Metronidazole

    2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition
  • An unusual presentation of QT prolongation

    2016, Texas Heart Institute Journal
View all citing articles on Scopus
View full text